Detalles de la búsqueda
1.
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
J Infect Dis
; 223(10): 1707-1716, 2021 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966573
2.
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
Lancet
; 391(10120): 563-571, 2018 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29217375
3.
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
Lancet Infect Dis
; 23(10): 1175-1185, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390836
4.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37544326
Resultados
1 -
4
de 4
1
Próxima >
>>